Advertisement

Contrast Media pp 193-200 | Cite as

Radiography with Gadolinium-Based Contrast Media

  • Henrik S. Thomsen
  • Peter Leander
Part of the Medical Radiology book series (MEDRAD)

Abstract

The atomic weight of gadolinium renders it radio-opaque at the KeVs used for radiography. Based on the incorrect assumption that gadolinium-based contrast media were not nephrotoxic, several investigators started using gadolinium-based contrast media for radiography, including CT, in patients with reduced renal function instead of using iodine-based contrast media. Nephrotoxicity of gadolinium-based contrast agents when used for radiographic studies, CT and MRI has now been described in both man and animals with renal impairment. Nephrogenic systemic fibrosis is another important adverse reaction after some gadolinium-based contrast media in patients with renal impairment. Gadolinium-based contrast media should not be used as contrast agents for radiography, including CT, in patients with reduced renal function. Gadolinium-based contrast media may be helpful for radiography in patients with normal renal function who have had multiple severe adverse reactions to iodine-based contrast media.

Keywords

Contrast Agent Contrast Medium Digital Subtraction Angiography Iodine Atom Nephrogenic Systemic Fibrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Akgun H, Gonlusen G, Cartwright J et al (2006) Are gadolinium based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med 130:1354–1357PubMedGoogle Scholar
  2. Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878–882PubMedGoogle Scholar
  3. Bittner CA, Goodwin SC, Lu D et al (1997) Gadolinium-based contrast agents for angiographic use as a safe radiocontrast in patients with impaired renal function. J Vasc Interv Radiol [Suppl] 8:178Google Scholar
  4. Bridges MD, St. Amant BS, McNeil RB et al (2009) High-dose gadodiamide for catheter angiography and CT in patients with varying degrees of renal insufficiency: prevalence of subsequent nephrogenic systemic fibrosis and decline in renal function. AJR Am J Roentgenol 192:1538–1543PubMedCrossRefGoogle Scholar
  5. Brillet G, Dubois M, Beaufils H et al (1994) Renal tolerance of gadolinium-DOTA and gadolinium- DTPA in rats. Invest Radiol 29:352–354PubMedCrossRefGoogle Scholar
  6. Brown PWG, Haylor JL, Morcos SK, El Nahas AM (1993) The functional effects of gadolinium-DTPA on the isolated perfused rat kidney. Eur J Radiol 16:85–89PubMedCrossRefGoogle Scholar
  7. Coche EE, Hammer FD, Gofette PP (2001) Demonstration of pulmonary embolism with dynamic gadolinium-enhanced spiral CT. Eur Radiol 11:2306–2309PubMedCrossRefGoogle Scholar
  8. Deray G, Dubois M, Martinez F et al (1990) Renal effects of radiocontrast agents in rats: A new model of acute renal failure. Am J Nephrol 10:507–513PubMedCrossRefGoogle Scholar
  9. Elmstahl B, Nyman U, Leander P et al (2004) Gadolinium contrast media are more nephrotoxic than low dose iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs. Acad Radiol 11:1219–1228PubMedCrossRefGoogle Scholar
  10. Elmstahl B, Nyman U, Leander P et al (2008) Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys. Radiology 247:88–97PubMedCrossRefGoogle Scholar
  11. Engelbrecht V, Koch JA, Rassek M, Mödder U (1996) Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography. Röfo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 165:24–28PubMedCrossRefGoogle Scholar
  12. Fujisaki K, Ono-Fujisaki A, Kura-Nakamura N et al (2011) Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent. Clin Nephrol 75:251–254PubMedCrossRefGoogle Scholar
  13. Gemery J, Idelson B, Reid S et al (1998) Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR Am J Roentgenol 171:1277–1278PubMedCrossRefGoogle Scholar
  14. Gemmete JJ, Forauer AR, Kazanjian S et al (2001) Safety of large volume gadolinium angiography. J Vasc Interv Radiol 12(part 2):S28Google Scholar
  15. Hammer FD, Gofette PP, Maliase J, Mathurin P (1999) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9:128–136PubMedCrossRefGoogle Scholar
  16. Henes FOG, Groth M, Begemann PGC et al (2011) Intraindividual comparison of gadolinium and iodine-enhanced 64-slice multidetector CT pulmonary angiography for the detection of pulmonary embolism in a porcine model. Emerg Radiol 18:189–195PubMedCrossRefGoogle Scholar
  17. Hoppe H, Spagnuolo S, Froehlich JM et al (2010) Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents. Eur Radiol 20:595–603PubMedCrossRefGoogle Scholar
  18. Hui FK, Tong FC, Dion JE (2011) The use of gadolinium chelates as an alternative radiographic contrast agent for use with flat panel detector angiography. J Neurointervent Surg 3:95–97CrossRefGoogle Scholar
  19. Idée J-M, Port M, Raynal I et al (2006) Clinical and biological consequences of trans- metallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576PubMedCrossRefGoogle Scholar
  20. Janon EA (1989) Gadolinium-DTPA: a radiographic contrast agent. AJR Am J Roentgenol 152:1348PubMedCrossRefGoogle Scholar
  21. Joffe P, Thomsen HS, Meusel M (1998) The pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency treated conservatively or undergoing hemo- dialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5:491–502PubMedCrossRefGoogle Scholar
  22. Kaufmann JA, Geller SC, Bazari H, Waltman AC (1999) Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency—early experiences. Radiology 212:280–284CrossRefGoogle Scholar
  23. Leander P, Allard P, Caillé JM, Golman K (1992) Early effect of gadopentate and iodinated contrast media on rabbit kidneys. Invest Radiol 27:922–926PubMedCrossRefGoogle Scholar
  24. Matchett WJ, McFarland DR, Russell DK et al (1996) Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Radiology 201:569–571PubMedGoogle Scholar
  25. Niendorf HP, Gifford LM, Haustein J et al (1991) Tolerance data of Gd-DTPA: a review. Eur J Radiol 13:15–20PubMedCrossRefGoogle Scholar
  26. Normann PT, Joffe P, Martinsen I, Thomsen HS (2000) Identification and quantification of gadodiamide in serum, peritoneal dialysate and faeces from end-stage renal patients dosed with gadodiamide injection by inductively coupled plasma-atomic emission spectroscopy and comparative analysis by high-performance liquid chromatography. J Pharma Biomed Anal 22:939–947CrossRefGoogle Scholar
  27. Nyman U, Elmstahl B, Leander P et al (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311–318PubMedCrossRefGoogle Scholar
  28. Nyman U, Elmstahl B, Leander P, Almén T (2008) Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients! Eur Radiol 18:2013–2014PubMedCrossRefGoogle Scholar
  29. Prince MR, Arnoldus C, Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. JMRI 1:162–166CrossRefGoogle Scholar
  30. Saleh L, Juneman E, Movahed MR (2011) The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention or vascular procedure. Catheter Cardiovasc Interven 78:747–754CrossRefGoogle Scholar
  31. Sam AD II, Morasch MD, Collins J et al (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313–318PubMedCrossRefGoogle Scholar
  32. Sambol EB, van der Meer JG, Graham A et al (2011) The use of gadolinium for arterial interventions. Ann Vasc Surg 25:366–376PubMedCrossRefGoogle Scholar
  33. Schenker MP, Solomon JA, Roberts DA (2001) Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Interv Radiol 12:393PubMedCrossRefGoogle Scholar
  34. Spinosa DJ, Matsumo AH, Angle JF et al (1998) Gadolinium based contrast and carbon dioxide angiography to evaluate transplants for vascular causes of renal insufficiency and accelerated hypertension. J Vasc Interv Radiol 9:909–916PubMedCrossRefGoogle Scholar
  35. Spinosa DJ, Matsumoto AH, Hagspiel KD et al (1999) Gadolinium-based contrast agents in angiography and interventional radiology. AJR Am J Roentgenol 173:1403–1409PubMedCrossRefGoogle Scholar
  36. Spinosa DJ, Angle JF, Hagspiel KD et al (2000) Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency. JVIR 11:35–43PubMedCrossRefGoogle Scholar
  37. Terzi C, Sokmen S (1999) Acute pancreatitis induced by magnetic-resonance-imaging contrast agent. Lancet 354:1789–1790PubMedCrossRefGoogle Scholar
  38. Thomsen HS (1997) Frequency of acute adverse events to a nonionic low-osmolar contrast medium: the effect of verbal interview. Pharmacol Toxicol 80:108–110PubMedCrossRefGoogle Scholar
  39. Thomsen HS (2003) ESUR Guidelines in contrast media. Am J Roentgenol 181:1461–1471CrossRefGoogle Scholar
  40. Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 14:1654–1656PubMedGoogle Scholar
  41. Thomsen HS, Dorph S, Larsen S et al (1994) Urine profiles and kidney histology after intravenous injection of ionic and nonionic radiologic and magnetic resonance contrast media in normal rats. Acad Radiol 1:128–135PubMedCrossRefGoogle Scholar
  42. Thomsen HS, Dorph S, Larsen S et al (1995) Urine profiles and kidney histology after intravenous injection of ionic and nonionic radiologic and magnetic resonance contrast media in rats with cisplatin nephropathy. Acad Radiol 2:675–682PubMedCrossRefGoogle Scholar
  43. Thomsen HS, Almén T, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600–2605PubMedGoogle Scholar
  44. Velmas T, Markkola T (1998) Gd-DTPA as an alternative contrast agent in conventional and interventional radiology. Acta Radiol 39:223–226Google Scholar
  45. Weinmann HJ (1999) Gadolinium chelates: physico-chemical properties, formulation and toxicology. In: Dawson P, Cosgrove DO, Grainger RG (eds) Textbook of contrast media. Isis Medical Media, Oxford, p 228Google Scholar
  46. Weinmann JH, Press WR, Gries H (1990) Tolerance of extracellular contrast agents for magnetic resonance imaging. Invest Radiol 25:S49–S50PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyCopenhagen University Hospital HerlevHerlevDenmark
  2. 2.Department of RadiologySkåne University HospitalMalmöSweden

Personalised recommendations